NIKA PHARMACEUTICALS, INC. Business Combination, Acquisition Related Costs
NIKA PHARMACEUTICALS, INC. (NIKA) reported Business Combination, Acquisition Related Costs of $150.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2024-04-01
- NIKA PHARMACEUTICALS, INC. business combination, acquisition related costs for the quarter ending 2022-12-31 was $0.00.
- NIKA PHARMACEUTICALS, INC. business combination, acquisition related costs for the quarter ending 2022-09-30 was $0.00.
- NIKA PHARMACEUTICALS, INC. business combination, acquisition related costs for the quarter ending 2022-06-30 was $150.00K.
- NIKA PHARMACEUTICALS, INC. business combination, acquisition related costs for fiscal 2022 was $150.00K.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $150.00K derived: sum of 3 quarters · filed 2024-04-01 | $150.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $150.00K derived: sum of 2 quarters · filed 2023-10-31 | $150.00K 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $150.00K 10-Q · filed 2023-08-21 | $150.00K 10-Q · filed 2023-08-21 |